| scholarly article | Q13442814 |
| P2093 | author name string | Qiaozhu Su | |
| Patricia Christian | |||
| P2860 | cites work | Pre-microRNA and mature microRNA in human mitochondria | Q21135367 |
| Multiple functions of microsomal triglyceride transfer protein | Q21245057 | ||
| Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia | Q24294711 | ||
| The nuclear RNase III Drosha initiates microRNA processing | Q24295234 | ||
| A human, ATP-independent, RISC assembly machine fueled by pre-miRNA | Q24298937 | ||
| MicroRNA maturation: stepwise processing and subcellular localization | Q24534359 | ||
| Tyrosine phosphorylation acts as a molecular switch to full-scale activation of the eIF2alpha RNA-dependent protein kinase | Q24535918 | ||
| Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs | Q24537328 | ||
| miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling | Q24627398 | ||
| Upregulation of Cyclin B1 by miRNA and its implications in cancer | Q24630059 | ||
| Endoplasmic reticulum stress and the inflammatory basis of metabolic disease | Q24633352 | ||
| Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis | Q24634165 | ||
| MicroRNA-373 induces expression of genes with complementary promoter sequences | Q24652547 | ||
| Most mammalian mRNAs are conserved targets of microRNAs | Q24655061 | ||
| Small dsRNAs induce transcriptional activation in human cells | Q24676787 | ||
| Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha | Q24683359 | ||
| Role of mitochondria in alcoholic liver disease | Q26864954 | ||
| Asymmetry in the assembly of the RNAi enzyme complex | Q27860763 | ||
| Silencing of microRNAs in vivo with 'antagomirs' | Q27860891 | ||
| Identification of tissue-specific microRNAs from mouse | Q27860892 | ||
| Functional siRNAs and miRNAs Exhibit Strand Bias | Q27861038 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Apolipoprotein B100 acts as a molecular link between lipid-induced endoplasmic reticulum stress and hepatic insulin resistance | Q28244602 | ||
| Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein | Q28249803 | ||
| Identification of scavenger receptor SR-BI as a high density lipoprotein receptor | Q28273182 | ||
| Human RISC couples microRNA biogenesis and posttranscriptional gene silencing | Q28280424 | ||
| Structure and function of carnitine acyltransferases | Q28297714 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis | Q28509140 | ||
| Regulation of progenitor cell proliferation and granulocyte function by microRNA-223 | Q28510667 | ||
| Nuclear miRNA regulates the mitochondrial genome in the heart | Q28575994 | ||
| Microsomal triacylglycerol transfer protein is required for lumenal accretion of triacylglycerol not associated with ApoB, as well as for ApoB lipidation | Q28590076 | ||
| P bodies and the control of mRNA translation and degradation | Q29547253 | ||
| miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting | Q29547487 | ||
| MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins | Q29615034 | ||
| LNA-mediated microRNA silencing in non-human primates | Q29615962 | ||
| IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030 | Q29620059 | ||
| MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion | Q29871530 | ||
| MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice | Q31132757 | ||
| Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells | Q33917885 | ||
| miR-33 links SREBP-2 induction to repression of sterol transporters | Q33981907 | ||
| MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation | Q34079793 | ||
| MicroRNA‐205–directed transcriptional activation of tumor suppressor genes in prostate cancer | Q34133056 | ||
| Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr-/- mice--brief report | Q34148844 | ||
| MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo | Q34182469 | ||
| Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation | Q34231924 | ||
| MicroRNAs 125a and 455 repress lipoprotein-supported steroidogenesis by targeting scavenger receptor class B type I in steroidogenic cells | Q34304540 | ||
| Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance | Q34399523 | ||
| miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. | Q34592976 | ||
| Activating gene expression in mammalian cells with promoter-targeted duplex RNAs | Q34607180 | ||
| Hepatic mitochondrial and ER stress induced by defective PPARα signaling in the pathogenesis of hepatic steatosis. | Q34790153 | ||
| Hepatic insulin resistance, metabolic syndrome and cardiovascular disease | Q34985312 | ||
| Endoplasmic reticulum stress and the development of diabetes: a review | Q35022174 | ||
| MicroRNA miR-324-3p induces promoter-mediated expression of RelA gene | Q35050493 | ||
| MicroRNA-208a increases myocardial fibrosis via endoglin in volume overloading heart | Q35083325 | ||
| The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. | Q35090215 | ||
| MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis | Q35091092 | ||
| Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. | Q35606800 | ||
| Interferons induce tyrosine phosphorylation of the eIF2alpha kinase PKR through activation of Jak1 and Tyk2. | Q35658377 | ||
| Lipids and lipoproteins in patients with type 2 diabetes | Q35783120 | ||
| MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. | Q35819417 | ||
| MicroRNA-30c-2* limits expression of proadaptive factor XBP1 in the unfolded protein response | Q35841763 | ||
| Autoregulation of microRNA biogenesis by let-7 and Argonaute | Q36069528 | ||
| MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis | Q36129123 | ||
| Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. | Q36129129 | ||
| Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents | Q36183590 | ||
| Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378*. | Q36279936 | ||
| miR-211 is a prosurvival microRNA that regulates chop expression in a PERK-dependent manner. | Q36392923 | ||
| Lipid and lipoprotein dysregulation in insulin resistant states | Q36397461 | ||
| MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-/- mice | Q36519806 | ||
| MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition | Q36826818 | ||
| Estimating deaths from cardiovascular disease: a review of global methodologies of mortality measurement | Q37016372 | ||
| Getting to the root of miRNA-mediated gene silencing | Q37055551 | ||
| IRE1α cleaves select microRNAs during ER stress to derepress translation of proapoptotic Caspase-2. | Q37091581 | ||
| Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome | Q37195515 | ||
| Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression | Q37280624 | ||
| Chromatin remodeling by the small RNA machinery in mammalian cells | Q37591539 | ||
| Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144. | Q37593879 | ||
| Apolipoprotein B100 biogenesis: a complex array of intracellular mechanisms regulating folding, stability, and lipoprotein assembly | Q37746984 | ||
| miRNA*: a passenger stranded in RNA-induced silencing complex? | Q37816459 | ||
| Early steps in reverse cholesterol transport: cholesteryl ester hydrolase and other hydrolases | Q37977329 | ||
| miRNAs: their discovery, biogenesis and mechanism of action | Q38085958 | ||
| MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor | Q38898464 | ||
| NLRP3 inflammasome activity is negatively controlled by miR-223. | Q39277506 | ||
| Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1β production | Q39277512 | ||
| IRE1α induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. | Q39299575 | ||
| Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections | Q39474763 | ||
| miR-378(∗) mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway | Q39648802 | ||
| MiR-33 contributes to the regulation of cholesterol homeostasis. | Q39704194 | ||
| The N-terminal 1000 residues of apolipoprotein B associate with microsomal triglyceride transfer protein to create a lipid transfer pocket required for lipoprotein assembly | Q40729235 | ||
| From pseudo-ceRNAs to circ-ceRNAs: a tale of cross-talk and competition | Q42835741 | ||
| Identification of mouse liver mitochondria-associated miRNAs and their potential biological functions | Q42928317 | ||
| Glucosamine-induced endoplasmic reticulum stress attenuates apolipoprotein B100 synthesis via PERK signaling | Q43073146 | ||
| Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. | Q43887376 | ||
| Regulation of ABCA1 protein expression and function in hepatic and pancreatic islet cells by miR-145. | Q44139433 | ||
| Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling | Q44463863 | ||
| P433 | issue | 9 | |
| P921 | main subject | microRNA | Q310899 |
| metabolic syndrome | Q657193 | ||
| P304 | page(s) | E729-37 | |
| P577 | publication date | 2014-09-02 | |
| P1433 | published in | American Journal of Physiology - Endocrinology and Metabolism | Q15765671 |
| P1476 | title | MicroRNA regulation of mitochondrial and ER stress signaling pathways: implications for lipoprotein metabolism in metabolic syndrome | |
| P478 | volume | 307 |
| Q36308978 | Differentially expressed miRNAs in sepsis-induced acute kidney injury target oxidative stress and mitochondrial dysfunction pathways |
| Q33916185 | Dysregulated miRNAs and their pathogenic implications for the neurometabolic disease propionic acidemia |
| Q58090817 | Endoplasmic reticulum stress epigenetics is related to adiposity, dyslipidemia, and insulin resistance |
| Q50679940 | Expression of microRNAs and target proteins in skeletal muscle of rats selectively bred for high and low running capacity. |
| Q26740458 | Inflammasomes in the Pathophysiology of Kidney Diseases |
| Q49884225 | Inositol-Requiring Enzyme 1 Facilitates Diabetic Wound Healing Through Modulating MicroRNAs |
| Q26780451 | MicroRNAs Regulate Mitochondrial Function in Cerebral Ischemia-Reperfusion Injury |
| Q36599274 | MicroRNAs and Noncoding RNAs in Hepatic Lipid and Lipoprotein Metabolism: Potential Therapeutic Targets of Metabolic Disorders |
| Q39071073 | MicroRNAs and the metabolic hallmarks of aging |
| Q26778376 | Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASH |
| Q26773008 | Possible Biomarkers in Blood for Crohn's Disease: Oxidative Stress and MicroRNAs-Current Evidences and Further Aspects to Unravel |
| Q58730164 | Regulation of Sphingolipid Metabolism by MicroRNAs: A Potential Approach to Alleviate Atherosclerosis |
| Q39654135 | Serum miRNA Signatures Are Indicative of Skeletal Fractures in Postmenopausal Women With and Without Type 2 Diabetes and Influence Osteogenic and Adipogenic Differentiation of Adipose Tissue-Derived Mesenchymal Stem Cells In Vitro. |
| Q26741668 | The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state |
| Q99567080 | The transcriptomic response of cells to a drug combination is more than the sum of the responses to the monotherapies |
Search more.